Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Rectal Neoplasms 10Colorectal Neoplasms 8Stomach Neoplasms 6Pancreatic Neoplasms 5Esophageal Neoplasms 5Colonic Neoplasms 5Breast Neoplasms 5Keratosis, Actinic 4Nasopharyngeal Neoplasms 3Nasopharyngeal Carcinoma 3Carcinoma, Hepatocellular 3Recurrence 2Neoplasms 2Head and Neck Neoplasms 2Carcinoma, Squamous Cell 2Uterine Cervical Neoplasms 1Pseudomyxoma Peritonei 1Peritoneal Neoplasms 1Pathologic Complete Response 1Neoplasm Metastasis 1Neoadjuvant Therapy 1Locally Advanced Rectal Cancer 1Keratosis 1Hyperthermia 1Gastrointestinal Neoplasms 1Esophageal Squamous Cell Carcinoma 1Appendiceal Neoplasms 1Anus Neoplasms 1Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction 1Advanced Colorectal Cancer 1

Interventions

pembrolizumab 1Folfox protocol 1Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Neoadjuvant Therapy × Fluorouracil × Clear all
NCT05352165 2022-04-28

The Clinical Efficacy of Drug Sensitive Neoadjuvant Chemotherapy Based on Organoid Versus Traditional Neoadjuvant Chemotherapy in Advanced Rectal Cancer

Shanghai Minimally Invasive Surgery Center

Phase NA Unknown
192 enrolled

Neoadjuvant Therapy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡